CIEN / Company research

Ciena earnings and filings

Financial results, original SEC reports and source-linked quarterly highlights.

SEC EDGAR / Collected

Latest available quarterly financial highlights

  • Revenue: $1.67 billion for the quarter from 2026-05-03 to 2026-08-01. Revenue changed +37.0% from the comparable prior-year quarter.

  • Operating income / loss: $301.18 million for the quarter from 2026-05-03 to 2026-08-01.

  • Net income / loss: $266.42 million for the quarter from 2026-05-03 to 2026-08-01.

  • Diluted EPS: $1.83 for the quarter from 2026-05-03 to 2026-08-01.

Highlights are calculated from supported SEC financial facts, not investment recommendations or analyst estimates. Later filings may restate prior results. A newer announcement can precede the availability of structured financial facts.

Reports and results announcements

Ciena reports, filing dates and original SEC documents
FiledFormReport dateDocuments
10-Q Aug 1, 2026 Quarterly reportAll exhibits and attachments
8-K Sep 3, 2026 Results announcement (Item 2.02)All exhibits and attachments
10-Q May 2, 2026 Quarterly reportAll exhibits and attachments
8-K Jun 4, 2026 Results announcement (Item 2.02)All exhibits and attachments
10-Q Jan 31, 2026 Quarterly reportAll exhibits and attachments
8-K Mar 5, 2026 Results announcement (Item 2.02)All exhibits and attachments
10-K Nov 1, 2025 Annual reportAll exhibits and attachments
8-K Dec 11, 2025 Results announcement (Item 2.02)All exhibits and attachments
10-Q Aug 2, 2025 Quarterly reportAll exhibits and attachments
8-K Sep 4, 2025 Results announcement (Item 2.02)All exhibits and attachments
10-Q May 3, 2025 Quarterly reportAll exhibits and attachments
8-K Jun 5, 2025 Results announcement (Item 2.02)All exhibits and attachments
10-Q Feb 1, 2025 Quarterly reportAll exhibits and attachments
8-K Mar 11, 2025 Results announcement (Item 2.02)All exhibits and attachments
10-K Nov 2, 2024 Annual reportAll exhibits and attachments
8-K Dec 12, 2024 Results announcement (Item 2.02)All exhibits and attachments

An 8-K marked Item 2.02 announces results; the earnings release or presentation may be an exhibit under “All exhibits and attachments.” Filings are official source documents, not an audit performed by this publication.

CIEN annual investment, R&D and cash flow

Quarterly highlights and original SEC reports

Verified annual USD facts from SEC filings. Collected .

Annual period Revenue Cash capex Productive asset purchases Operating cash flow Free cash flow R&D R&D / revenue
to $4.77 billion $140.8 million Not available $806.09 million $665.29 million $848.33 million 17.8%
Revenues · 10-K filed · accession 0001628280-25-056698
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0001628280-25-056698
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0001628280-25-056698
ResearchAndDevelopmentExpense · 10-K filed · accession 0001628280-25-056698
to $4.01 billion $136.64 million Not available $514.53 million $377.89 million $767.5 million 19.1%
Revenues · 10-K filed · accession 0001628280-25-056698
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0001628280-25-056698
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0001628280-25-056698
ResearchAndDevelopmentExpense · 10-K filed · accession 0001628280-25-056698
to $4.39 billion $106.2 million Not available $168.33 million $62.14 million $750.56 million 17.1%
Revenues · 10-K filed · accession 0001628280-25-056698
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0001628280-25-056698
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0001628280-25-056698
ResearchAndDevelopmentExpense · 10-K filed · accession 0001628280-25-056698
to $3.63 billion $90.82 million Not available -$167.76 million -$258.57 million $624.66 million 17.2%
Revenues · 10-K filed · accession 0000936395-24-000044
NetCashProvidedByUsedInOperatingActivities · 10-K filed · accession 0000936395-24-000044
PaymentsToAcquirePropertyPlantAndEquipment · 10-K filed · accession 0000936395-24-000044
ResearchAndDevelopmentExpense · 10-K filed · accession 0000936395-24-000044
SEC filing data: definitions, coverage and revisions

Source: the SEC Company Facts API, using standard US GAAP facts in USD from annual 10-K, 20-F or 40-F filings and amendments. Periods must span 300-400 days. Quarterly and year-to-date values are not presented as annual totals.

  • Cash capex is cash payments to acquire property, plant and equipment. It excludes broader acquisition or intangible-asset tags and is not total AI spending or an estimate of finance-lease investment.
  • Productive asset purchases are a separately reported, broader cash investment measure. They are shown in their own column and never substituted into PP&E capex, capital intensity or free cash flow. Do not rank mixed definitions as if they were identical.
  • Free cash flow here is operating cash flow minus cash capex. It may differ from a company's adjusted free cash flow definition. If either input is missing, the result is omitted.
  • R&D intensity is reported research and development expense divided by revenue from the same annual reporting period. Operating cash margin and capital intensity use the same-period revenue denominator.
  • Figures are company-wide, not AI-specific or segment-level. Financial years differ, so compare the displayed start and end dates rather than assuming calendar-year alignment.
  • The latest available filing for each supported fact is used, including restated comparative figures. Conflicting values from equally recent reports are omitted. Every figure retains its XBRL tag, accession and filing date.

Company-specific extension tags, IFRS-only data and unsupported definitions are not estimated. Missing standard facts are shown as unavailable, not zero. Data is refreshed in the background; the collection time is separate from the filing date.